Purchase this article with an account.
Caio V. Regatieri, Juliana L. Dreyfuss, Gustavo B. Melo, Daniel Lavinsky, Michel E. Farah, Helena B. Nader; Dual Role of Intravitreous Infliximab in Experimental Choroidal Neovascularization: Effect on the Expression of Sulfated Glycosaminoglycans. Invest. Ophthalmol. Vis. Sci. 2009;50(11):5487-5494. doi: 10.1167/iovs.08-3171.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To determine effects of intravitreous anti-TNF-α (infliximab) in a laser-induced choroidal neovascularization (CNV) model by fluorescein angiogram (FA), immunofluorescence, ELISA, and glycosaminoglycan analyses.
CNV induction was performed using argon laser. Rats were divided into eight groups (no-laser no-infliximab; laser; laser with 10, 20, 40, 80, or 320 μg infliximab; and isotype-matched IgG). After 3 weeks, CNV area was measured by FA and von Willebrand factor (vWF) immunofluorescence. VEGF, TGF-β, and syndecan-4 were evaluated by ELISA and immunofluorescence. Glycosaminoglycan expression was determined in retina and choroid of animals metabolically labeled with [35S]-sulfate. Cytotoxicity was investigated using ARPE-19 and endothelial cells.
FA showed significant reduction in the low-dose infliximab groups (10–40 μg), confirmed by vWF immunofluorescence that showed 49% decrease in the CNV. VEGF and TGF-β decreased expression detected by ELISA and immunofluorescence paralleled these results. Similar data were observed for syndecan-4. The expression of these molecules in the neovascularization area using 320 μg was similar to the no-infliximab laser group or laser with isotype-matched IgG. Heparan sulfate expression in retina and choroid paralleled the observed effects on angiogenesis. Increased expression of chondroitin sulfate in retina and dermatan sulfate in choroid reflects the effects of injury and fibrosis using high doses of anti-TNF-α. Infliximab showed no cytotoxic effect in ARPE-19 cells, whereas high doses led to 20% decrease in endothelial cell viability.
Intravitreal infliximab shows dual effect on the development of laser-induced CNV. It reduces angiogenesis and glycosaminoglycan expression at low doses, whereas opposite effects are observed at high doses.
This PDF is available to Subscribers Only